Abstract digital waveforms in blue and purple

FDA Drug information

Eslicarbazepine acetate

Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)

Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE 200 mg/1 Apotex Corp.
Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE 200 mg/1 Ascend Laboratories, LLC
Eslicarbazepine acetate ESLICARBAZEPINE ACETATE 200 mg/1 Camber Pharmaceuticals, Inc.
Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE 200 mg/1 Dr.Reddys Laboratories Inc
Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE 200 mg/1 Lupin Pharmaceuticals, Inc.
Eslicarbazepine acetate ESLICARBAZEPINE ACETATE 200 mg/1 Torrent Pharmaceuticals Limited
Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE 400 mg/1 Apotex Corp.
Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE 400 mg/1 Ascend Laboratories, LLC
Eslicarbazepine acetate ESLICARBAZEPINE ACETATE 400 mg/1 Camber Pharmaceuticals, Inc.
Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE 400 mg/1 Dr.Reddys Laboratories Inc
Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE 400 mg/1 Lupin Pharmaceuticals, Inc.
Eslicarbazepine acetate ESLICARBAZEPINE ACETATE 400 mg/1 Torrent Pharmaceuticals Limited
Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE 600 mg/1 Apotex Corp.
Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE 600 mg/1 Ascend Laboratories, LLC
Eslicarbazepine acetate ESLICARBAZEPINE ACETATE 600 mg/1 Camber Pharmaceuticals, Inc.
Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE 600 mg/1 Dr.Reddys Laboratories Inc
Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE 600 mg/1 Lupin Pharmaceuticals, Inc.
Eslicarbazepine acetate ESLICARBAZEPINE ACETATE 600 mg/1 Torrent Pharmaceuticals Limited
Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE 800 mg/1 Apotex Corp.
Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE 800 mg/1 Ascend Laboratories, LLC
Eslicarbazepine acetate ESLICARBAZEPINE ACETATE 800 mg/1 Camber Pharmaceuticals, Inc.
Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE 800 mg/1 Dr.Reddys Laboratories Inc
Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE 800 mg/1 Lupin Pharmaceuticals, Inc.
Eslicarbazepine acetate ESLICARBAZEPINE ACETATE 800 mg/1 Torrent Pharmaceuticals Limited

Learning Zones

Learning Zone

HLH/MAS comprehensive clinical guide

1 mins

Light microscopy of the internal lining of the urinary bladder; haematoxylin and eosin stain

Overview

Managing High-Risk NMIBC

1 mins

Photo of Prostate cancer cells under microscope, pink and purple tones.

Prostate Cancer Nexus

1 mins

Cerebellum, Thalamus, Medulla oblongata, Spinal cord and Motor Neuron human under the microscope in Lab. Orange colours

Overview

Chronic Inflammatory Demyelinating Polyneuropathy

1 mins

Prostatic tissue biopsy; Sections show fatty tissue, neural tissue and muscle tissue; Prostate cancer diagnosis

Learning Zone

HRR mutation testing in mPC

1 mins

8 year old child with redness and peeling of the skin on the body.

Overview

Atopic Dermatitis in Paediatric Patients

1 mins

Illustration; activated mast cell releasing histamine; AI generated

Learning Zone

Chronic Spontaneous Urticaria Academy

1 mins

Unrecognizable female doctor holding graphic virtual visualization model of Lungs organ in hands. Multiple medical icons on the background.

Learning Zone

Type 2 Inflammation in COPD

1 mins

Learning Zone

Advances in Lymphoma

1 mins

Blood clot blocking a blood vessel 3D graphic

Learning Zone

THINK THROMBOSIS: Individualised care

1 mins

UCB EHSF 2024 teaser tile image of 'medical summit'

Learning Zone

Advances in HS

30 mins

Learning Zone

Herpes Zoster Learning Zone

165 mins

Learning Zone

Type 2 Inflammation in Upper & Lower Airway Diseases

1 mins

Overview

Treatment selection in HIV Learning Zone

125 mins

Learning Zone

Hidradenitis Suppurativa Academy

120 mins

Learning Zone

Psoriasis Academy

910 mins

Learning Zone

Myasthenia Gravis Learning Zone

110 mins

Learning Zone

Growth Hormone Deficiency

150 mins

Learning Zone

Alopecia areata Learning Zone

60 mins

Learning Zone

Severe Asthma Learning Zone

100 mins

Learning Zone

mCRPC in focus

1 mins

CMKD, Kidney disease, AI generated image

Learning Zone

Complement-mediated kidney diseases

205 mins

Myocardium Cardiac muscle fibers banner image

Learning Zone

Pompe Disease: Key findings from WMS 2022

150 mins

Doctor holding patients hand in consultation

Learning Zone

Supportive care in oncology Learning Zone

150 mins

Learning Zone

Albumin in fluid management

115 mins

Learning Zone

Glaucoma Learning Zone

190 mins

Image of AI generated blood clot formation that would require pharmacological treatments available for various vascular conditions, such as anticoagulants, anti platelet agents, and vasodilators

Learning Zone

Antiplatelet therapy in ACS: Choices and Controversies

270 mins

patient receiving dialysis, hospital image

Learning Zone

Chronic Kidney Disease Learning Zone

340 mins

Learning Zone

Hidradenitis suppurativa

220 mins

Learning Zone

Multiple Sclerosis (MS) Learning Zone

160 mins

Learning Zone

Lupus Learning Zone

240 mins

Learning Zone

Inflammatory Bowel Disease Learning Zone

100 mins

Learning Zone

Diagnosis and management of primary hyperoxaluria type 1

110 mins

Learning Zone

CDK4/6 inhibitors in breast cancer

199 mins

Patient and doctor in consultation, advice on tobacco use

Learning Zone

Very Brief Advice for Tobacco Dependency

155 mins

Learning Zone

Fibrinogen Deficiency in Bleeding Learning Zone

160 mins

Learning Zone

Oral Anticoagulation Reversal Learning Zone

355 mins

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.